[Activ Surgical] Activ Surgical Announces Completion of First In-Human Procedures Demonstrating Impa

[Hyperfine] Hyperfine Announces Receipt of Additional $3.3 Million Grant to Improve Access to Neonat

[Activ Surgical] Activ Surgical raises $45 million Series B round to give surgeons eagle eyes

[Hyperfine] Hyperfine Announces Plans for Global Expansion Starting with Launches in the United King

[Senda Biosciences] Fierce Biotech Names Senda Biosciences a 2021

[인게니움] 이엔셀, 인게니움테라퓨틱스와 ‘난치성 백혈병치료제’ 위탁생산 계약

[Activ Surgical] FDA clears Activ Surgical hardware for enhanced surgical visualization

[KeyProteo] Direct Measurement of ATP7B Peptides Is Highly Effective in the Diagnosis of Wilson Dise

[Hyperfine] Veteran Medical Device and Innovation Leader Dave Scott President and CEO